| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oncology Nursing | 19 | 2020 | 29 | 4.820 |
Why?
|
| Neoplasms | 41 | 2023 | 2758 | 4.580 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 31 | 2023 | 805 | 4.400 |
Why?
|
| Fatigue | 27 | 2023 | 216 | 4.050 |
Why?
|
| Pediatric Nursing | 17 | 2020 | 39 | 4.010 |
Why?
|
| F2-Isoprostanes | 4 | 2023 | 23 | 2.720 |
Why?
|
| Leukemia | 8 | 2022 | 375 | 2.720 |
Why?
|
| Oxidative Stress | 13 | 2021 | 795 | 2.470 |
Why?
|
| Nursing Research | 6 | 2020 | 16 | 2.430 |
Why?
|
| Antineoplastic Agents | 15 | 2023 | 1661 | 2.180 |
Why?
|
| Parents | 10 | 2021 | 1031 | 1.930 |
Why?
|
| Nausea | 12 | 2020 | 97 | 1.870 |
Why?
|
| Education, Nursing, Continuing | 4 | 2020 | 19 | 1.830 |
Why?
|
| Child | 94 | 2025 | 24240 | 1.780 |
Why?
|
| Pain | 13 | 2022 | 470 | 1.620 |
Why?
|
| Patient Discharge | 3 | 2021 | 485 | 1.580 |
Why?
|
| Nursing Staff, Hospital | 5 | 2020 | 60 | 1.420 |
Why?
|
| Adolescent | 62 | 2024 | 19110 | 1.320 |
Why?
|
| Evidence-Based Nursing | 5 | 2018 | 10 | 1.240 |
Why?
|
| Nurse's Role | 3 | 2020 | 35 | 1.240 |
Why?
|
| Attitude to Health | 5 | 2012 | 259 | 1.240 |
Why?
|
| Quality of Life | 12 | 2023 | 1929 | 1.230 |
Why?
|
| Vomiting | 8 | 2015 | 115 | 1.210 |
Why?
|
| Child, Preschool | 46 | 2024 | 13888 | 1.180 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 5 | 2015 | 1198 | 1.140 |
Why?
|
| Health Education | 3 | 2016 | 225 | 1.050 |
Why?
|
| Survivors | 5 | 2019 | 345 | 1.040 |
Why?
|
| Pediatrics | 11 | 2018 | 1141 | 1.040 |
Why?
|
| Cognition | 7 | 2021 | 736 | 1.030 |
Why?
|
| Glutathione | 2 | 2018 | 193 | 1.010 |
Why?
|
| Methotrexate | 10 | 2019 | 341 | 1.010 |
Why?
|
| Sleep Wake Disorders | 10 | 2021 | 173 | 0.980 |
Why?
|
| Nursing Process | 2 | 2015 | 2 | 0.960 |
Why?
|
| Biomarkers | 9 | 2023 | 2946 | 0.960 |
Why?
|
| Evidence-Based Medicine | 4 | 2012 | 622 | 0.950 |
Why?
|
| Antioxidants | 2 | 2018 | 338 | 0.940 |
Why?
|
| Humans | 107 | 2025 | 123223 | 0.920 |
Why?
|
| Cell Phone | 2 | 2014 | 29 | 0.900 |
Why?
|
| Hematologic Neoplasms | 2 | 2019 | 286 | 0.900 |
Why?
|
| Ifosfamide | 4 | 2014 | 39 | 0.890 |
Why?
|
| Practice Guidelines as Topic | 10 | 2019 | 1262 | 0.890 |
Why?
|
| Male | 71 | 2024 | 60117 | 0.880 |
Why?
|
| Carnitine | 3 | 2014 | 78 | 0.870 |
Why?
|
| Quality Improvement | 6 | 2018 | 625 | 0.820 |
Why?
|
| Medical Oncology | 8 | 2021 | 214 | 0.810 |
Why?
|
| Illness Behavior | 2 | 2013 | 8 | 0.810 |
Why?
|
| Cisplatin | 4 | 2014 | 242 | 0.800 |
Why?
|
| Female | 71 | 2024 | 65549 | 0.800 |
Why?
|
| Doxorubicin | 4 | 2014 | 299 | 0.790 |
Why?
|
| Hospice and Palliative Care Nursing | 1 | 2022 | 18 | 0.780 |
Why?
|
| Stress, Psychological | 3 | 2019 | 556 | 0.770 |
Why?
|
| Longitudinal Studies | 13 | 2022 | 1309 | 0.760 |
Why?
|
| Adaptation, Psychological | 7 | 2021 | 459 | 0.750 |
Why?
|
| Antimetabolites, Antineoplastic | 7 | 2018 | 178 | 0.740 |
Why?
|
| Catheterization, Central Venous | 2 | 2015 | 132 | 0.730 |
Why?
|
| Nurses, Pediatric | 1 | 2020 | 3 | 0.720 |
Why?
|
| Stem Cell Transplantation | 2 | 2014 | 239 | 0.710 |
Why?
|
| Clinical Studies as Topic | 1 | 2020 | 10 | 0.710 |
Why?
|
| Nurse-Patient Relations | 1 | 2020 | 17 | 0.700 |
Why?
|
| Education, Distance | 1 | 2020 | 66 | 0.660 |
Why?
|
| Exercise | 6 | 2023 | 808 | 0.660 |
Why?
|
| Education, Nursing, Baccalaureate | 1 | 2019 | 9 | 0.650 |
Why?
|
| Advanced Practice Nursing | 1 | 2019 | 9 | 0.640 |
Why?
|
| Patient Education as Topic | 2 | 2020 | 451 | 0.640 |
Why?
|
| Child, Hospitalized | 2 | 2011 | 73 | 0.640 |
Why?
|
| Symptom Assessment | 1 | 2019 | 98 | 0.630 |
Why?
|
| Catheterization, Peripheral | 1 | 2020 | 126 | 0.630 |
Why?
|
| Cross Infection | 2 | 2015 | 331 | 0.630 |
Why?
|
| Transitional Care | 1 | 2019 | 20 | 0.630 |
Why?
|
| Patient Handoff | 1 | 2019 | 26 | 0.620 |
Why?
|
| Nitrosative Stress | 1 | 2018 | 2 | 0.620 |
Why?
|
| Hematologic Diseases | 2 | 2025 | 78 | 0.610 |
Why?
|
| Writing | 1 | 2019 | 59 | 0.610 |
Why?
|
| Curriculum | 3 | 2019 | 719 | 0.600 |
Why?
|
| Palliative Care | 1 | 2022 | 429 | 0.600 |
Why?
|
| Tyrosine | 1 | 2018 | 152 | 0.590 |
Why?
|
| Oxidation-Reduction | 3 | 2018 | 444 | 0.590 |
Why?
|
| Caspase 3 | 1 | 2018 | 131 | 0.590 |
Why?
|
| Publishing | 1 | 2019 | 108 | 0.580 |
Why?
|
| Hospitals, Pediatric | 6 | 2009 | 779 | 0.580 |
Why?
|
| Syndrome | 6 | 2022 | 1115 | 0.580 |
Why?
|
| Continuity of Patient Care | 1 | 2019 | 154 | 0.560 |
Why?
|
| Health Personnel | 2 | 2019 | 499 | 0.550 |
Why?
|
| Caregivers | 2 | 2020 | 572 | 0.540 |
Why?
|
| Professional-Family Relations | 2 | 2016 | 95 | 0.540 |
Why?
|
| Peripheral Nervous System Diseases | 3 | 2023 | 128 | 0.530 |
Why?
|
| Educational Status | 1 | 2016 | 270 | 0.490 |
Why?
|
| Graft vs Host Disease | 2 | 2010 | 542 | 0.490 |
Why?
|
| Prospective Studies | 14 | 2020 | 6040 | 0.480 |
Why?
|
| Africa South of the Sahara | 4 | 2025 | 121 | 0.480 |
Why?
|
| Patient Care Bundles | 1 | 2015 | 23 | 0.470 |
Why?
|
| Surveys and Questionnaires | 13 | 2019 | 3670 | 0.470 |
Why?
|
| Ethics Committees, Research | 1 | 2014 | 33 | 0.460 |
Why?
|
| Affective Symptoms | 1 | 2014 | 60 | 0.450 |
Why?
|
| Albumins | 1 | 2014 | 87 | 0.450 |
Why?
|
| Severity of Illness Index | 9 | 2017 | 2839 | 0.430 |
Why?
|
| Catheter-Related Infections | 1 | 2015 | 131 | 0.420 |
Why?
|
| Cluster Analysis | 3 | 2011 | 400 | 0.420 |
Why?
|
| Venous Thromboembolism | 1 | 2015 | 161 | 0.410 |
Why?
|
| Self Care | 2 | 2013 | 212 | 0.410 |
Why?
|
| Neutropenia | 1 | 2014 | 202 | 0.410 |
Why?
|
| Quality Assurance, Health Care | 2 | 2012 | 207 | 0.400 |
Why?
|
| Cancer Care Facilities | 1 | 2012 | 30 | 0.390 |
Why?
|
| Information Dissemination | 1 | 2014 | 187 | 0.390 |
Why?
|
| Apoptosis | 2 | 2018 | 1781 | 0.390 |
Why?
|
| Texas | 11 | 2019 | 3560 | 0.380 |
Why?
|
| Hematology | 1 | 2012 | 38 | 0.380 |
Why?
|
| Bacterial Infections | 1 | 2014 | 305 | 0.380 |
Why?
|
| Conscious Sedation | 1 | 2012 | 63 | 0.380 |
Why?
|
| Lymphoma | 1 | 2014 | 321 | 0.370 |
Why?
|
| Analgesia | 1 | 2011 | 44 | 0.360 |
Why?
|
| Hospitalization | 3 | 2015 | 1726 | 0.360 |
Why?
|
| Anticoagulants | 1 | 2015 | 581 | 0.350 |
Why?
|
| Analgesics | 1 | 2011 | 135 | 0.340 |
Why?
|
| United States | 10 | 2020 | 10637 | 0.330 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 351 | 0.320 |
Why?
|
| Incidence | 7 | 2020 | 3048 | 0.320 |
Why?
|
| Ambulatory Care | 1 | 2012 | 377 | 0.320 |
Why?
|
| Dyslipidemias | 1 | 2012 | 229 | 0.320 |
Why?
|
| Nursing Assessment | 4 | 2011 | 26 | 0.320 |
Why?
|
| Lipids | 1 | 2012 | 515 | 0.310 |
Why?
|
| Inservice Training | 1 | 2009 | 55 | 0.310 |
Why?
|
| Chronic Disease | 1 | 2013 | 1168 | 0.310 |
Why?
|
| Child Behavior | 4 | 2011 | 232 | 0.290 |
Why?
|
| Health Facility Environment | 1 | 2007 | 8 | 0.290 |
Why?
|
| Infant | 9 | 2020 | 12349 | 0.290 |
Why?
|
| Adult | 12 | 2024 | 29072 | 0.280 |
Why?
|
| Motor Skills | 1 | 2007 | 85 | 0.280 |
Why?
|
| Attitude of Health Personnel | 1 | 2012 | 641 | 0.280 |
Why?
|
| Diffusion of Innovation | 1 | 2007 | 97 | 0.270 |
Why?
|
| Growth Disorders | 1 | 2008 | 207 | 0.270 |
Why?
|
| Motivation | 2 | 2019 | 314 | 0.270 |
Why?
|
| Staff Development | 1 | 2006 | 45 | 0.260 |
Why?
|
| Middle Aged | 10 | 2024 | 26016 | 0.260 |
Why?
|
| Risk Factors | 11 | 2022 | 10015 | 0.260 |
Why?
|
| Parent-Child Relations | 3 | 2016 | 250 | 0.260 |
Why?
|
| Nursing Methodology Research | 4 | 2010 | 15 | 0.260 |
Why?
|
| Cancer Survivors | 2 | 2019 | 199 | 0.250 |
Why?
|
| Hemoglobins | 3 | 2006 | 301 | 0.250 |
Why?
|
| Capacity Building | 1 | 2025 | 25 | 0.240 |
Why?
|
| Legal Guardians | 1 | 2024 | 13 | 0.240 |
Why?
|
| Adolescent Behavior | 3 | 2011 | 171 | 0.230 |
Why?
|
| Sepsis | 1 | 2009 | 477 | 0.230 |
Why?
|
| Gastrointestinal Diseases | 1 | 2008 | 334 | 0.230 |
Why?
|
| Cognition Disorders | 3 | 2017 | 555 | 0.230 |
Why?
|
| Feasibility Studies | 4 | 2017 | 753 | 0.230 |
Why?
|
| Infant, Newborn | 5 | 2020 | 8108 | 0.220 |
Why?
|
| Antiemetics | 2 | 2015 | 23 | 0.220 |
Why?
|
| Malawi | 2 | 2024 | 389 | 0.220 |
Why?
|
| Medical Staff | 1 | 2003 | 8 | 0.220 |
Why?
|
| Burkitt Lymphoma | 1 | 2024 | 145 | 0.210 |
Why?
|
| Child Welfare | 2 | 2015 | 66 | 0.210 |
Why?
|
| Depression | 5 | 2022 | 1217 | 0.210 |
Why?
|
| Time Factors | 5 | 2012 | 6221 | 0.200 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 123 | 0.200 |
Why?
|
| Anemia | 2 | 2005 | 340 | 0.190 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2018 | 1232 | 0.190 |
Why?
|
| Dexamethasone | 3 | 2022 | 272 | 0.190 |
Why?
|
| Checklist | 2 | 2019 | 85 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2014 | 1682 | 0.180 |
Why?
|
| Prevalence | 4 | 2022 | 2406 | 0.180 |
Why?
|
| Karnofsky Performance Status | 2 | 2011 | 14 | 0.180 |
Why?
|
| Delphi Technique | 1 | 2022 | 202 | 0.180 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2024 | 420 | 0.180 |
Why?
|
| Body Weight | 2 | 2015 | 1001 | 0.180 |
Why?
|
| Saudi Arabia | 1 | 2020 | 39 | 0.180 |
Why?
|
| Self Report | 2 | 2014 | 510 | 0.170 |
Why?
|
| Catheters | 1 | 2020 | 89 | 0.170 |
Why?
|
| Follow-Up Studies | 4 | 2024 | 5049 | 0.170 |
Why?
|
| Suicidal Ideation | 1 | 2022 | 194 | 0.170 |
Why?
|
| Logistic Models | 2 | 2017 | 1793 | 0.170 |
Why?
|
| Job Satisfaction | 1 | 2020 | 78 | 0.170 |
Why?
|
| Students, Nursing | 1 | 2019 | 19 | 0.160 |
Why?
|
| Age Factors | 4 | 2018 | 2802 | 0.160 |
Why?
|
| Hodgkin Disease | 1 | 2002 | 293 | 0.160 |
Why?
|
| Body Mass Index | 3 | 2015 | 1541 | 0.160 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2020 | 165 | 0.160 |
Why?
|
| Consensus | 1 | 2022 | 612 | 0.160 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2020 | 227 | 0.160 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2024 | 826 | 0.150 |
Why?
|
| Home Nursing | 1 | 2018 | 17 | 0.150 |
Why?
|
| Disease Progression | 2 | 2017 | 2025 | 0.150 |
Why?
|
| Psychomotor Performance | 3 | 2015 | 188 | 0.150 |
Why?
|
| Program Development | 2 | 2009 | 190 | 0.150 |
Why?
|
| Attention | 1 | 2019 | 197 | 0.150 |
Why?
|
| Achievement | 1 | 2017 | 32 | 0.140 |
Why?
|
| Dyssomnias | 2 | 2007 | 2 | 0.140 |
Why?
|
| Organizational Culture | 2 | 2009 | 95 | 0.140 |
Why?
|
| Stress, Physiological | 1 | 2019 | 258 | 0.140 |
Why?
|
| Phosphatidylcholines | 4 | 2015 | 41 | 0.140 |
Why?
|
| Motor Activity | 3 | 2015 | 522 | 0.140 |
Why?
|
| Memory Disorders | 2 | 2011 | 235 | 0.140 |
Why?
|
| Lipid Peroxidation | 2 | 2015 | 82 | 0.140 |
Why?
|
| Prognosis | 4 | 2024 | 4514 | 0.130 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2017 | 92 | 0.130 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 2478 | 0.130 |
Why?
|
| Evidence-Based Practice | 1 | 2017 | 110 | 0.130 |
Why?
|
| Injections, Spinal | 2 | 2014 | 117 | 0.130 |
Why?
|
| Research Design | 1 | 2020 | 685 | 0.130 |
Why?
|
| Program Evaluation | 2 | 2009 | 450 | 0.130 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2018 | 216 | 0.130 |
Why?
|
| Health Status Disparities | 1 | 2018 | 218 | 0.130 |
Why?
|
| Pain Measurement | 2 | 2008 | 356 | 0.130 |
Why?
|
| Psychology, Child | 2 | 2008 | 47 | 0.130 |
Why?
|
| Reading | 1 | 2016 | 80 | 0.130 |
Why?
|
| Neuropsychological Tests | 4 | 2021 | 924 | 0.130 |
Why?
|
| Behavior | 1 | 2015 | 75 | 0.120 |
Why?
|
| Erythropoietin | 2 | 2006 | 104 | 0.120 |
Why?
|
| Child Development | 1 | 2017 | 261 | 0.120 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 477 | 0.120 |
Why?
|
| Adolescent Health Services | 1 | 2015 | 38 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 372 | 0.120 |
Why?
|
| Educational Measurement | 1 | 2017 | 324 | 0.120 |
Why?
|
| Human Experimentation | 1 | 2014 | 37 | 0.110 |
Why?
|
| Sleep | 3 | 2021 | 345 | 0.110 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 260 | 0.110 |
Why?
|
| Research Subjects | 1 | 2014 | 55 | 0.110 |
Why?
|
| Child Health Services | 1 | 2015 | 86 | 0.110 |
Why?
|
| Southwestern United States | 2 | 2015 | 46 | 0.110 |
Why?
|
| Odds Ratio | 1 | 2017 | 1243 | 0.110 |
Why?
|
| Mood Disorders | 1 | 2014 | 125 | 0.110 |
Why?
|
| Databases, Bibliographic | 1 | 2013 | 20 | 0.110 |
Why?
|
| Sickness Impact Profile | 1 | 2013 | 36 | 0.110 |
Why?
|
| Retrospective Studies | 6 | 2018 | 16033 | 0.100 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 730 | 0.100 |
Why?
|
| Mass Screening | 1 | 2018 | 788 | 0.100 |
Why?
|
| Guideline Adherence | 1 | 2015 | 375 | 0.100 |
Why?
|
| Nursing Records | 1 | 2012 | 5 | 0.100 |
Why?
|
| Nursing Evaluation Research | 1 | 2012 | 7 | 0.100 |
Why?
|
| Education, Continuing | 1 | 2012 | 29 | 0.100 |
Why?
|
| Brain Diseases | 1 | 2015 | 296 | 0.100 |
Why?
|
| Phospholipids | 1 | 2012 | 107 | 0.100 |
Why?
|
| Mathematics | 1 | 2011 | 100 | 0.090 |
Why?
|
| Iatrogenic Disease | 1 | 2012 | 132 | 0.090 |
Why?
|
| Statistics as Topic | 1 | 2012 | 250 | 0.090 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 432 | 0.090 |
Why?
|
| Acute Chest Syndrome | 1 | 2011 | 9 | 0.090 |
Why?
|
| Central Nervous System | 1 | 2012 | 254 | 0.090 |
Why?
|
| Survival Rate | 1 | 2015 | 1996 | 0.090 |
Why?
|
| Convalescence | 1 | 2010 | 5 | 0.090 |
Why?
|
| Patient Care | 1 | 2011 | 100 | 0.090 |
Why?
|
| Decision Making | 2 | 2024 | 653 | 0.090 |
Why?
|
| Pediatric Obesity | 1 | 2015 | 379 | 0.090 |
Why?
|
| Risk Assessment | 2 | 2018 | 3316 | 0.090 |
Why?
|
| Patient Satisfaction | 1 | 2013 | 476 | 0.080 |
Why?
|
| Social Support | 1 | 2012 | 345 | 0.080 |
Why?
|
| Psychometrics | 2 | 2011 | 657 | 0.080 |
Why?
|
| Guidelines as Topic | 1 | 2011 | 197 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 3378 | 0.080 |
Why?
|
| Nursing Education Research | 1 | 2009 | 3 | 0.080 |
Why?
|
| Clinical Nursing Research | 2 | 2011 | 6 | 0.080 |
Why?
|
| Hematinics | 2 | 2006 | 57 | 0.080 |
Why?
|
| Equipment Contamination | 1 | 2009 | 38 | 0.080 |
Why?
|
| Transplantation, Homologous | 1 | 2010 | 659 | 0.080 |
Why?
|
| Arizona | 2 | 2019 | 25 | 0.080 |
Why?
|
| Adenosine Triphosphate | 1 | 2009 | 287 | 0.080 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2010 | 254 | 0.080 |
Why?
|
| Stearic Acids | 1 | 2008 | 5 | 0.080 |
Why?
|
| Palmitic Acid | 1 | 2008 | 35 | 0.080 |
Why?
|
| Q-Sort | 1 | 2008 | 1 | 0.080 |
Why?
|
| Translating | 1 | 2008 | 31 | 0.070 |
Why?
|
| Linear Models | 1 | 2010 | 669 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 6372 | 0.070 |
Why?
|
| Audiovisual Aids | 1 | 2008 | 25 | 0.070 |
Why?
|
| Models, Nursing | 1 | 2007 | 6 | 0.070 |
Why?
|
| Communication Barriers | 1 | 2008 | 39 | 0.070 |
Why?
|
| Phlebotomy | 1 | 2007 | 17 | 0.070 |
Why?
|
| Anthropometry | 1 | 2008 | 197 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 586 | 0.070 |
Why?
|
| Infection Control | 1 | 2009 | 160 | 0.070 |
Why?
|
| Organizational Objectives | 1 | 2007 | 33 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2014 | 973 | 0.070 |
Why?
|
| Child Nutrition Disorders | 1 | 2008 | 76 | 0.070 |
Why?
|
| Multilingualism | 1 | 2008 | 43 | 0.070 |
Why?
|
| Efficiency, Organizational | 1 | 2007 | 50 | 0.070 |
Why?
|
| Models, Organizational | 1 | 2007 | 40 | 0.070 |
Why?
|
| Young Adult | 3 | 2015 | 8865 | 0.070 |
Why?
|
| Electronic Health Records | 1 | 2014 | 705 | 0.070 |
Why?
|
| Bone Marrow Transplantation | 1 | 2010 | 577 | 0.070 |
Why?
|
| Nutrition Assessment | 1 | 2008 | 133 | 0.070 |
Why?
|
| Anemia, Sickle Cell | 1 | 2011 | 334 | 0.070 |
Why?
|
| Anemia, Hypochromic | 1 | 2006 | 8 | 0.070 |
Why?
|
| Global Health | 1 | 2011 | 557 | 0.070 |
Why?
|
| Information Services | 1 | 2006 | 22 | 0.070 |
Why?
|
| Professional Competence | 1 | 2007 | 97 | 0.070 |
Why?
|
| Anxiety | 1 | 2013 | 957 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2020 | 4710 | 0.070 |
Why?
|
| Focus Groups | 1 | 2007 | 199 | 0.070 |
Why?
|
| Review Literature as Topic | 1 | 2006 | 45 | 0.070 |
Why?
|
| Infusions, Intravenous | 3 | 2015 | 537 | 0.070 |
Why?
|
| Information Storage and Retrieval | 1 | 2006 | 60 | 0.070 |
Why?
|
| Verbal Learning | 1 | 2006 | 66 | 0.060 |
Why?
|
| Perception | 1 | 2007 | 220 | 0.060 |
Why?
|
| Activities of Daily Living | 1 | 2007 | 405 | 0.060 |
Why?
|
| Patient-Centered Care | 1 | 2007 | 225 | 0.060 |
Why?
|
| Bone Marrow | 1 | 2006 | 323 | 0.060 |
Why?
|
| Stomatitis | 1 | 2004 | 13 | 0.060 |
Why?
|
| Energy Metabolism | 1 | 2009 | 769 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2010 | 702 | 0.060 |
Why?
|
| Aged | 2 | 2019 | 19098 | 0.060 |
Why?
|
| Wit and Humor as Topic | 1 | 2003 | 2 | 0.060 |
Why?
|
| Obesity | 1 | 2015 | 2226 | 0.060 |
Why?
|
| Internet | 1 | 2006 | 378 | 0.050 |
Why?
|
| Patient Participation | 1 | 2006 | 220 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2015 | 338 | 0.050 |
Why?
|
| Needs Assessment | 1 | 2004 | 173 | 0.050 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2004 | 174 | 0.050 |
Why?
|
| Hand Strength | 1 | 2022 | 42 | 0.050 |
Why?
|
| Physical Examination | 1 | 2023 | 164 | 0.050 |
Why?
|
| Vincristine | 1 | 2022 | 196 | 0.050 |
Why?
|
| Qualitative Research | 1 | 2024 | 520 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 2586 | 0.050 |
Why?
|
| Executive Function | 1 | 2021 | 106 | 0.050 |
Why?
|
| Sarcoma, Ewing | 1 | 2002 | 116 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2007 | 2830 | 0.040 |
Why?
|
| Periodicals as Topic | 1 | 2003 | 195 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2003 | 391 | 0.040 |
Why?
|
| Pilot Projects | 3 | 2011 | 1388 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2007 | 821 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 594 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 1088 | 0.040 |
Why?
|
| Rhabdomyosarcoma | 1 | 2002 | 200 | 0.040 |
Why?
|
| Osteosarcoma | 1 | 2002 | 257 | 0.040 |
Why?
|
| Physical Endurance | 1 | 2018 | 46 | 0.040 |
Why?
|
| Brain | 1 | 2010 | 2964 | 0.040 |
Why?
|
| Disabled Children | 1 | 2018 | 25 | 0.040 |
Why?
|
| Patient Outcome Assessment | 1 | 2018 | 94 | 0.040 |
Why?
|
| Goals | 1 | 2018 | 130 | 0.040 |
Why?
|
| Self Efficacy | 1 | 2018 | 193 | 0.040 |
Why?
|
| Bone Neoplasms | 1 | 2002 | 429 | 0.040 |
Why?
|
| Metabolomics | 1 | 2020 | 409 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2002 | 509 | 0.030 |
Why?
|
| Recurrence | 1 | 2020 | 1423 | 0.030 |
Why?
|
| Epoetin Alfa | 2 | 2006 | 12 | 0.030 |
Why?
|
| Health Behavior | 1 | 2018 | 381 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2018 | 449 | 0.030 |
Why?
|
| Perioperative Care | 1 | 2017 | 195 | 0.030 |
Why?
|
| Phosphatidylinositols | 1 | 2015 | 32 | 0.030 |
Why?
|
| Southeastern United States | 1 | 2015 | 39 | 0.030 |
Why?
|
| Nephrectomy | 1 | 2015 | 172 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2017 | 366 | 0.030 |
Why?
|
| Sphingomyelins | 1 | 2012 | 16 | 0.030 |
Why?
|
| Phosphatidylethanolamines | 1 | 2012 | 22 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2006 | 1386 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2017 | 1009 | 0.020 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2015 | 255 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2006 | 1590 | 0.020 |
Why?
|
| Mathematical Concepts | 1 | 2011 | 8 | 0.020 |
Why?
|
| Length of Stay | 1 | 2017 | 1284 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2015 | 387 | 0.020 |
Why?
|
| Taste Disorders | 1 | 2010 | 2 | 0.020 |
Why?
|
| Xerostomia | 1 | 2010 | 9 | 0.020 |
Why?
|
| Psychology, Adolescent | 1 | 2010 | 33 | 0.020 |
Why?
|
| Anorexia | 1 | 2010 | 28 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2010 | 107 | 0.020 |
Why?
|
| Verbal Behavior | 1 | 2009 | 52 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 1877 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 1414 | 0.020 |
Why?
|
| Chromatography, Gas | 1 | 2008 | 30 | 0.020 |
Why?
|
| Intelligence Tests | 1 | 2008 | 57 | 0.020 |
Why?
|
| ROC Curve | 1 | 2010 | 557 | 0.020 |
Why?
|
| NAD | 1 | 2008 | 48 | 0.020 |
Why?
|
| Patients' Rooms | 1 | 2007 | 9 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 424 | 0.020 |
Why?
|
| Bicycling | 1 | 2007 | 39 | 0.020 |
Why?
|
| Emotions | 1 | 2009 | 359 | 0.020 |
Why?
|
| Wechsler Scales | 1 | 2006 | 21 | 0.020 |
Why?
|
| Vocabulary | 1 | 2006 | 24 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 2026 | 0.020 |
Why?
|
| Memory | 1 | 2009 | 361 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2008 | 1008 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2017 | 3014 | 0.020 |
Why?
|
| Erythrocyte Transfusion | 1 | 2006 | 122 | 0.020 |
Why?
|
| Placebos | 1 | 2005 | 238 | 0.020 |
Why?
|
| Memory, Short-Term | 1 | 2006 | 140 | 0.020 |
Why?
|
| Health Status | 1 | 2006 | 374 | 0.010 |
Why?
|
| Genotype | 1 | 2010 | 2542 | 0.010 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 2003 | 20 | 0.010 |
Why?
|
| Psychological Theory | 1 | 2003 | 32 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 2005 | 301 | 0.010 |
Why?
|
| Life Change Events | 1 | 2003 | 59 | 0.010 |
Why?
|
| Social Adjustment | 1 | 2003 | 85 | 0.010 |
Why?
|
| Saliva | 1 | 2003 | 113 | 0.010 |
Why?
|
| Models, Psychological | 1 | 2003 | 136 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 2006 | 395 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 12141 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2005 | 861 | 0.010 |
Why?
|
| Family | 1 | 2006 | 578 | 0.010 |
Why?
|
| Self Concept | 1 | 2003 | 157 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2003 | 771 | 0.010 |
Why?
|